Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0000950170-24-109450

Chief Accounting Officer sold 2,352 shares at $5.98 ($14,065)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Liao Carrie Chief Accounting Officer 2024-09-25 Sale 10b5-1 −2,352 $5.98 $14,065 99,543 D
Open-market sales · 2,352 sh · avg $5.98 · $14,065
Loading xslF345X05/ownership.xml…